Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today.
Revenues were $16.7 billion, down 6% on a reported basis and 7% on an operational basis year-over-year.
Net income decreased 21% to $3.5 billion, or $0.62 per share, compared to last year. Adjusted EPS declined 18% to $0.87.
Revenue and earnings beat expectations.
For the full year of 2025, Pfizer expects revenue of $61-64 billion. Adjusted EPS is now expected to be $3.00-3.15.
The stock stayed red during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
